Sueoka E, Sueoka N, Goto Y, Matsuyama S, Nishimura H, Sato M, Fujimura S, Chiba H, Fujiki H
Saitama Cancer Center Research Institute, Kitaadachi-gun, Japan.
Cancer Res. 2001 Mar 1;61(5):1896-902.
Heterogeneous nuclear ribonucleoprotein (hnRNP) B1 is a RNA-binding protein of Mr 37,000. We previously reported that hnRNP B1 was specifically overexpressed in the nuclei of human lung cancer cells, particularly in squamous cell carcinoma (E. Sueoka et al., Cancer Res., 59: 1404-1407, 1999). We extended this study to determine whether hnRNP BL was overexpressed in roentgenographically occult cancers of the lungs and premalignant lesions of squamous cell carcinomas, such as bronchial dysplasia. The additional object of our study was to examine the usefulness of hnRNP B1 as a potential diagnostic marker for squamous cell carcinoma of various organs, such as the oral cavity and esophagus in humans. Surgically resected specimens of bronchial dysplasia, lung cancers, and various human squamous cell carcinomas, collected at two hospitals in Japan, were subjected to immunohistochemical staining with anti-hnRNP B1 antibody. Overexpression of hnRNP B1 protein was observed in 100% of stage I lung cancer tissues, but it was not found in normal bronchial epithelium. Squamous cell carcinoma of the lungs showed stronger staining than other histological types, and elevation of hnRNP B1 was found in both roentgenographically occult lung cancers and bronchial dysplasia. Furthermore, cytological examination with anti-hnRNP B1 antibody detected cancer cells in sputum, suggesting the potential of hnRNP B1 protein as a new biomarker for the very early stage of lung cancer in humans. Because strong staining of hnRNP B1 was also observed in various squamous cell carcinomas of oral and esophageal tissues as shown in our recent reports, overexpression of hnRNP B1 seems to be a common event in the carcinogenic processes of squamous cell carcinoma. These results suggest that hnRNP B1 protein could be a useful diagnostic biomarker for both the very early stages of lung cancer and various squamous cell carcinomas in humans.
不均一核核糖核蛋白(hnRNP)B1是一种分子量为37000的RNA结合蛋白。我们之前报道过hnRNP B1在人肺癌细胞核中特异性过表达,尤其是在鳞状细胞癌中(E. Sueoka等人,《癌症研究》,59: 1404 - 1407,1999)。我们扩展了这项研究,以确定hnRNP BL是否在肺部影像学隐匿性癌症和鳞状细胞癌的癌前病变(如支气管发育异常)中过表达。我们研究的另一个目的是检验hnRNP B1作为人类口腔和食管等各种器官鳞状细胞癌潜在诊断标志物的实用性。在日本的两家医院收集的手术切除的支气管发育异常、肺癌和各种人类鳞状细胞癌标本,用抗hnRNP B1抗体进行免疫组织化学染色。在100%的I期肺癌组织中观察到hnRNP B1蛋白过表达,但在正常支气管上皮中未发现。肺鳞状细胞癌的染色比其他组织学类型更强,在影像学隐匿性肺癌和支气管发育异常中均发现hnRNP B1升高。此外,用抗hnRNP B1抗体进行细胞学检查在痰液中检测到癌细胞,提示hnRNP B1蛋白作为人类肺癌极早期新生物标志物的潜力。正如我们最近的报告所示,在口腔和食管组织的各种鳞状细胞癌中也观察到hnRNP B1的强染色现象,hnRNP B1过表达似乎是鳞状细胞癌致癌过程中的常见事件。这些结果表明,hnRNP B1蛋白可能是人类肺癌极早期和各种鳞状细胞癌的有用诊断生物标志物。